Wellnex Life Pushes Loan Repayment to July with $150K Fee Added

Loan Repayment Extension and Financial Terms

Wellnex Life Limited (ASX/AIM: WNX) has secured an extension for repaying approximately $2.88 million in loans owed to former directors, pushing the deadline from 20 April to 21 July 2026. The company agreed to pay an additional $150,000 rolled into the loan principal as consideration for this extension, with interest accruing at a steep 10% rate. There is also an option to extend repayment further to 21 August 2026, contingent on a further $50,000 fee added to the principal.

This arrangement includes a clause for accelerated repayment should Wellnex receive cleared funds from any corporate transaction, such as asset sales or capital raisings, sufficient to cover the loan. This mechanism aims to reduce interest costs if liquidity improves suddenly.

Former CEO Returns in Advisory Role

In a notable governance move, Wellnex has brought back former CEO Zack Bozinovski as a consultant to provide advisory and project-based services. This rehiring could signal the company’s intent to leverage his experience during a period of financial restructuring and strategic repositioning. Bozinovski’s involvement may also reflect continuity in leadership thinking amid ongoing efforts to stabilise the business.

Financial Position and Strategic Implications

The loan extension comes as Wellnex navigates a delicate balance between managing legacy debt and pursuing growth opportunities. Earlier this year, the company reported a sharp improvement in cash flow and revenue growth, partly attributed to strategic brand consolidation and cost discipline. This progress was highlighted in the company’s recent update on its cash flow improvement in Q2 FY26, which showed a 31.5% revenue increase quarter-on-quarter and a near break-even operating cash flow.

However, the need to extend director loan repayments underscores ongoing liquidity challenges. The company’s willingness to pay fees to delay repayment and the high interest rate on the loan principal suggest pressure on cash resources. The accelerated repayment clause tied to corporate transactions hints at possible asset sales or capital raises in the near term, although details remain unspecified.

Wellnex’s recent moves, including extending a key supply deal with Haleon UK and exploring strategic acquisitions and convertible note funding, indicate a broader effort to strengthen its financial footing and expand its portfolio. The loan extension and Bozinovski’s consultancy role fit within this broader narrative of cautious financial management paired with strategic exploration.